StimCell Energetics Inc. reported its financial results for the three months ending August 31, 2026, revealing a net loss of $169,518, a decrease from the $265,602 loss recorded in the same period the previous year. The company’s total operating expenses for the quarter were $146,558, significantly lower than the $252,354 reported for the three months ended August 31, 2025. This reduction in expenses was primarily attributed to decreased consulting fees and general administrative costs, which fell to $7,500 and $67,296, respectively, compared to $34,830 and $139,484 in the prior year.
As of August 31, 2026, StimCell's total assets amounted to $60,946, a decline from $81,454 at the end of the previous fiscal year on May 31, 2026. The company’s liabilities increased to $2,032,473, up from $1,892,774, largely due to rising amounts owed to related parties, which reached $684,074. The accumulated deficit also widened to $11,926,449 from $11,756,931, reflecting ongoing financial challenges. The company ended the quarter with cash reserves of $6,883, a slight increase from $3,057 at the end of May 2026.
In terms of operational metrics, the weighted average number of shares outstanding increased to 21,141,272 from 20,319,261 year-over-year. The company did not report any significant changes in customer counts or product adoption rates during this period. However, it continues to rely on financing from related parties to support its operations, with total notes and advances due to related parties rising to $965,200 as of August 31, 2026.
Looking ahead, StimCell management has indicated plans to seek additional debt or equity financing to address its working capital deficit of $1,971,527 and to ensure the company can meet its obligations. The financial statements highlight substantial doubt about the company's ability to continue as a going concern within the next year, contingent on securing sufficient financing. The company’s future performance will depend on its ability to stabilize its financial position and potentially expand its product offerings in the competitive biotech market.
About Stimcell Energetics Inc.
Stimcell Energetics Inc. develops microcurrent-based devices aimed at enhancing cellular function, wellness, and managing health conditions such as diabetes, pain, and neuropathy. Its proprietary eBalance® technology supports health through electrical therapy systems for clinical and home use. The company focuses on research, regulatory approval, and commercialization of its medical devices, targeting chronic disease management and wellness markets worldwide.
About 10-Q Filings
A 10-Q form is an important financial report that public companies in the United States must submit every three months. It gives a clear picture of a company's financial health and recent performance.
Key points about the 10-Q:
- Frequency: Companies file it three times a year, covering the first three quarters. The fourth quarter is covered in a more comprehensive annual report.
-
Content: It includes:
- Financial statements showing the company's current financial position
- Updates from management on the performance and projections of the business
- Information about potential risks the company faces
- Details on how the company is run internally
- Deadline: Must be filed within 40 or 45 days after the quarter ends, depending on the size of the company.
Our Methodology
AssetRoom is committed to providing timely summaries of news from public companies. We use AI to generate these summaries quickly, but they are not reviewed by human experts.
Our method:
- Data Collection: We continuously monitor for new filings (currently limited to US-listed stocks).
- AI-Powered Analysis: Our advanced AI system processes each filing, identifying key information and extracting relevant data.
- Summary Generation: The AI creates a concise, easy-to-understand summary of the filing, highlighting the most important points.
- Publication: The summary is immediately published on our platform, allowing users instant access to the latest information.
- Email users: We distribute round-up emails according to our users preferences, keeping them in the loop with the companies they follow.
Feedback & Corrections
Spot an error or have a suggestion? Contact us.
View the complete official filing on the SEC website.
Read on SEC.gov